ACADIA PHARMACEUTICALS INC (ACAD) Free cash flow 2016–2025
ACADIA PHARMACEUTICALS INC (ACAD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$105.1MFY2025 · since FY2016: -$209.9M → $105.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $105.1M | -33.1% |
| FY2024 | $157.2M | +844.0% |
| FY2023 | $16.7M | +114.6% |
| FY2022 | -$114.0M | +10.1% |
| FY2021 | -$126.8M | +11.8% |
| FY2020 | -$143.8M | +5.6% |
| FY2019 | -$152.3M | +10.2% |
| FY2018 | -$169.6M | +22.4% |
| FY2017 | -$218.6M | -4.1% |
| FY2016 | -$209.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice